Please Wait
Applying Filters...
menu
    • menu
    ICE Pharma-PSE
    News
    ICE Pharma joined the fifth edition of “Fabbriche Aperte”

    30 Oct 2024

    // PRESS RELEASE

    the Ambassador of Italy visits ICE Japan plant

    23 Sep 2024

    // PRESS RELEASE

    The potential of bile acids as anti-COVID-19 therapies

    05 Jan 2024

    // PRESS RELEASE

    Data Compilation
    #PharmaFlow

    ICE S.p.A

    Contact Supplier

    Website

    Pharma, Lab & Chemical Expo

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    speak-pharma/ice-is-pioneering-sustainability-innovation-in-bile-acid-research-for-neurodegenerative-diseases
    Menu

    ICE Pharma

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    Key Products KEY PRODUCTS

    SERVICES

    EXCIPIENTS

    EXCIPIENTS BY INGREDIENTS

    EXCIPIENTS BY APPLICATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1Bile acid

    02 1Cholic acid

    03 1Lithocholic acid

    04 1N-Acetyl-D-Mannosamine

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    Contact SupplierContact Supplier
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.
    Contact Supplier Contact Supplier
    Flag Italy
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Bile acid

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    41945-48-6
    Cholic Acid
    ICE Pharma's core business includes the manufacture of active pharmaceutical ingredients, the most i...
    ICE Pharma's core business includes the manufacture of active pharmaceutical ingredients, the most important of which is Ursodeoxycholic Acid (UDCA), used to treat liver diseases and gallstones. The company develops and manufactures a range of bile acid derivatives that are used as excipients, nutraceutical ingredients, cell culture media, and intermediates. ICE Pharma also provides contract manufacturing services for liquid and solid finished dosage forms for branded and generic products. Since October 2019, ICE Pharma has been owned by Advent International, one of the largest and most experienced global private equity investors.
    ICE S.p.A

    01

    Bile acid

    Italy
    Pharma, Lab & Chemical Expo
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.

    ICE Pharma

    Bile acid

    CAS Number : 41945-48-6

    End Use API : Cholic Acid

    About the Company : ICE Pharma's core business includes the manufacture of active pharmaceutical ingredients, the most important of which is...

    ICE S.p.A

    Intermediate Web Link

    Market Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.
    Contact Supplier Contact Supplier
    Flag Italy
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Cholic acid

    Intermediate Web Link

    Market Place

    6282-60-6
    Ursodeoxycholic Acid
    ICE Pharma's core business includes the manufacture of active pharmaceutical ingredients, the most i...
    ICE Pharma's core business includes the manufacture of active pharmaceutical ingredients, the most important of which is Ursodeoxycholic Acid (UDCA), used to treat liver diseases and gallstones. The company develops and manufactures a range of bile acid derivatives that are used as excipients, nutraceutical ingredients, cell culture media, and intermediates. ICE Pharma also provides contract manufacturing services for liquid and solid finished dosage forms for branded and generic products. Since October 2019, ICE Pharma has been owned by Advent International, one of the largest and most experienced global private equity investors.
    ICE S.p.A

    02

    Cholic acid

    Italy
    Pharma, Lab & Chemical Expo
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.

    ICE Pharma

    Cholic acid

    CAS Number : 6282-60-6

    End Use API : Ursodeoxycholic Acid

    About the Company : ICE Pharma's core business includes the manufacture of active pharmaceutical ingredients, the most important of which is...

    ICE S.p.A

    Intermediate Web Link

    Market Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.
    Contact Supplier Contact Supplier
    Flag Italy
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Lithocholic acid

    Intermediate Web Link

    Market Place

    434-13-9
    Ursodeoxycholic Acid
    ICE Pharma's core business includes the manufacture of active pharmaceutical ingredients, the most i...
    ICE Pharma's core business includes the manufacture of active pharmaceutical ingredients, the most important of which is Ursodeoxycholic Acid (UDCA), used to treat liver diseases and gallstones. The company develops and manufactures a range of bile acid derivatives that are used as excipients, nutraceutical ingredients, cell culture media, and intermediates. ICE Pharma also provides contract manufacturing services for liquid and solid finished dosage forms for branded and generic products. Since October 2019, ICE Pharma has been owned by Advent International, one of the largest and most experienced global private equity investors.
    ICE S.p.A

    03

    Lithocholic acid

    Italy
    Pharma, Lab & Chemical Expo
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.

    ICE Pharma

    Lithocholic acid

    CAS Number : 434-13-9

    End Use API : Ursodeoxycholic Acid

    About the Company : ICE Pharma's core business includes the manufacture of active pharmaceutical ingredients, the most important of which is...

    ICE S.p.A

    Intermediate Web Link

    Market Place

    Contact Supplier
    • FDA
    • EDQM
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.
    Contact Supplier Contact Supplier
    Flag Italy
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    N-Acetyl-D-Mannosamine

    Intermediate Web Link

    Market Place

    7772-94-3
    N-Acetyl-D-neuraminate
    ICE Pharma's core business includes the manufacture of active pharmaceutical ingredients, the most i...
    ICE Pharma's core business includes the manufacture of active pharmaceutical ingredients, the most important of which is Ursodeoxycholic Acid (UDCA), used to treat liver diseases and gallstones. The company develops and manufactures a range of bile acid derivatives that are used as excipients, nutraceutical ingredients, cell culture media, and intermediates. ICE Pharma also provides contract manufacturing services for liquid and solid finished dosage forms for branded and generic products. Since October 2019, ICE Pharma has been owned by Advent International, one of the largest and most experienced global private equity investors.
    ICE S.p.A

    04

    N-Acetyl-D-Mannosamine

    Italy
    Pharma, Lab & Chemical Expo
    Not Confirmed
    arrow
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.

    ICE Pharma

    N-Acetyl-D-Mannosamine

    CAS Number : 7772-94-3

    End Use API : N-Acetyl-D-neuraminate

    About the Company : ICE Pharma's core business includes the manufacture of active pharmaceutical ingredients, the most important of which is...

    ICE S.p.A

    Intermediate Web Link

    Market Place

    Contact Ice Pharma and get a quotation

    Ice Pharma is a supplier offers 13 products (APIs, Excipients or Intermediates).

    Find a price of Ursodeoxycholic Acid bulk with DMF, CEP, JDMF offered by Ice Pharma

    Find a price of Chenodeoxycholic Acid bulk with DMF, CEP offered by Ice Pharma

    Find a price of Cholic Acid bulk with CEP, JDMF offered by Ice Pharma

    Find a price of Ursodeoxycholic Acid bulk with CEP, JDMF offered by Ice Pharma

    Find a price of Cholic Acid bulk with CEP offered by Ice Pharma

    Find a price of Deoxycholic Acid bulk with CEP offered by Ice Pharma

    Find a price of Tauroursodeoxycholic Acid bulk with DMF offered by Ice Pharma

    Find a price of Ursodeoxycholic Acid bulk with CEP offered by Ice Pharma

    Find a price of Dehydrocholic Acid bulk offered by Ice Pharma

    Find a price of Doxofylline bulk offered by Ice Pharma

    Find a price of Inosine Pranobex bulk offered by Ice Pharma

    Find a price of N-Acetyl-D-neuraminate bulk offered by Ice Pharma

    Find a price of Taurine bulk offered by Ice Pharma